glp-1 landscape glp1agonists #obesitytreatment #healthcareinnovation #novonordisk #elililly Glucagon-like Peptide-1 (GLP-1) Agonists Market

JPTs Diabetes Peptide%3b GLP-1 receptor agonists Glucagon-like Peptide 1 (GLP-1) and other GLP-1 receptor agonists have proven to be an effective treatment of Type 2 diabetes and obesity, offering significant benefits

A balanced diet and regular physical activity can significantly enhance their effectiveness, leading to more sustainable health outcomes

If further research yields positive results, it could drive even more demand for the highly popular GLP-1 treatments, which have increasingly been shown to help with problems across the body, such as heart and kidney complications

Satisfaction rating from patient experience survey results collected May 2025

GLP-1 or GLP-1R agonists display a diverse range of physiological functions as shown in the image below

10.1038/s41467-018-03941-2